Clinical Trial Update: Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pirfenidone combined with sildenafil in advanced idiopathic pulmonary fibrosis with potential pulmonary hypertension; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)
• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2020-11-12